March 15, 2018

FDA Grants Abeona Therapeutics Rare Pediatric Disease Designation

Abeona Therapeutics received a Rare Pediatric Disease Designation by the U.S. Food and Drug Administration for ABO-202, a gene therapy for the treatment of Batten disease.

Read More  >